Vasculopathy, Hematological, and Immune Abnormalities Associated with Levamisole-Contaminated Cocaine Use

Seminars in Arthritis and Rheumatism

Volumn 41, Issue 3, 2011, Pages 445-454

  Khan, Tahir A ^a   Cuchacovich, Raquel ^a   Espinoza, Luis R ^a   Lata, Suman ^a   Patel, Nirupa J ^a   Garcia Valladares, Ignacio ^a   Salassi, Michele M ^b   Sanders, Charles V ^b  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Agranulocytosis; Cocaine; Immune abnormalities; Levamisole; Retiform purpura; Vasculitis vasculopathy

Indexed keywords

AUTOANTIBODY; COCAINE; LEVAMISOLE; METHOTREXATE; PREDNISONE;

ADULT; ARTICLE; CASE REPORT; DISEASE ASSOCIATION; EAR; FEMALE; FOLLOW UP; HEMATOLOGIC DISEASE; HUMAN; HUMAN TISSUE; IMMUNOPATHOLOGY; LEUKOCYTOCLASTIC VASCULITIS; LEUKOCYTOSIS; LEUKOPENIA; LEVAMISOLE CONTAMINATED COCAINE INDUCED VASCULOPATHY; MALE; NEUTROPENIA; POLYCHONDRITIS; PRIORITY JOURNAL; PURPURA; SKIN BIOPSY; THROMBOSIS; VASCULAR DISEASE;

ANTIRHEUMATIC AGENTS; COCAINE; COCAINE-RELATED DISORDERS; DOPAMINE UPTAKE INHIBITORS; FEMALE; HUMANS; LEVAMISOLE; MALE; MIDDLE AGED; NEUTROPENIA; PURPURA; SKIN; VASCULITIS;

EID: 82955202770     PISSN: 00490172     EISSN: 1532866X     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2011.04.010     Document Type: Article

References (54)

1. Cregler L., Marh H. Medical complications of cocaine abuse. N Engl J Med 1986, 315:1495.
2. Agranulocytosis associated with cocaine use-four states, March 2008-November 2009. Morb Mortal Wkly Rep 2009, 58:1381-1385. Centers for Disease Control and Prevention.
3. Knowles L., Buxton J.A., Skuridina N., Achebe I., Legatt D., Fan S., et al. Levamisole tainted cocaine causing severe neutropenia in Alberta and British Columbia. Harm Reduct J 2009, 6:30.
4. Zhu N.Y., Legatt D.F., Turner A.R. Agranulocytosis after consumption of cocaine adulterated with levamisole. Ann Intern Med 2009, 150:287-289.
5. Wiens M.O., Son W.K., Ross C., Hayden M., Carleton B. Cases: Cocaine adulterant linked to neutropenia. CMAJ 2010, 182:57-59.
6. Czuchlewski D.R., Brackney M., Ewers C., Manna J., Fekrazad M.H., Martinez A., et al. Clinicopathologic features of agranulocytosis in the setting of levamisole tainted cocaine. Am J Clin Pathol 2010, 133:466.
7. Buchanan J.A., Oyer R.J., Patel N.R., Jacquet G.A., Bornikova L., Thienelt C., et al. A confirmed case of agranulocytosis after use of cocaine contaminated with levamisole. J Med Toxicol 2010, 6(2):160-164.
8. Walsh N.M., Green P.J., Burlingame R.W., Pasternak S., Hanly J.G. Cocaine-related retiform purpura: evidence to incriminate the adulterant, levamisole. J Cutan Pathol 2010, 37(12):1212-1219.
9. Bradford M., Rosenberg B., Moreno J., Dumyati G. Bilateral necrosis of earlobes and cheeks: another complication of cocaine contaminated with levamisole. Ann Intern Med 2010, 152(11):758-759.
10. Buchanan J.A., Vogel J.A., Eberhardt A.M. Levamisole-induced occlusive necrotizing vasculitis of the ears after use of cocaine contaminated with levamisole. J Med Toxicol 2010, 7(1):83-84.
11. Waller J.M., Feramisco J.D., Alberta-Wszolek L., McCalmont T.H., Fox L.P. Cocaine associated retiform purpura and neutropenia: Is levamisole the culprit?. J Am Acad Dermatol 2010, 63(3):530-535.
12. Farhat E.K., Muirhead T.T., Chaffins M.L., Douglass M.C. Levamisole-induced cutaneous necrosis mimicking coagulopathy. Arch Dermatol 2010, 146(11):1320-1321.
13. Lee B.L., Stone J.H., Gimbel D., Khosroshahi A. A 44-year-old woman with cutaneous bullae and extensive skin necrosis. Arthritis Care Res (Hoboken) 2010, 62(12):1805-1811.
14. Macfarlane D.G., Bacon P.A. Levamisole-induced vasculitis due to circulating immune complexes. Br Med J 1978, 1(6110):407-408.
15. Scheinberg M.A., Bezerra J.B., Almeida F.A., Silveira L.A. Cutaneous necrotising vasculitis induced by levamisole. Br Med J 1978, 1:408.
16. Rongioletti F., Ghio L., Ginevri F., Bleidl D., Rinaldi S., Edefonti A., et al. Purpura of the ears: a distinctive vasculopathy with circulating autoantibodies complicating long-term treatment with levamisole in children. Br J Dermatol 1999, 140(5):948-951.
17. Menni S., Pistritto G., Gianotti R., Ghio L., Edefonti A. Ear lobe bilateral necrosis by levamisole-induced occlusive vasculitis in a pediatric patient. Pediatr Dermatol 1997, 14(6):477-479.
18. Powell J., Grech H., Holder J. A boy with cutaneous necrosis occurring during treatment with levamisole. Clin Exp Dermatol 2002, 27:32-33.
19. Barbano G., Ginevri F., Ghiggeri G.M., Gusmano R. Disseminated autoimmune disease during levamisole treatment of nephritic syndrome. Pediatr Nephrol 1999, 13:602-603.
20. Laux-End R., Inaebnit D., Gerber H.A., Bianchetti M.G. Vasculitis associated with levamisole and circulating autoantibodies. Arch Dis Child 1996, 75:355-356.
21. Chang A., Osterloh J., Thomas J. Levamisole: A dangerous new cocaine adulterant. Clin Pharmacol Ther 2010, 88(3):408-411.
22. Valentino A.M.M., Fuentecilla K. Levamisole: An analytical profile. Microgram J 2005, 3(3-4):134-137.
23. Casale J.F., Corbeil E.M., Hays P.A. Identification of levamisole impurities found in illicit cocaine exhibits. DEA Microgram 2008, 6:3-5.
24. Nationwide Public Health Alert Issued Concerning Life-Threatening Risk Posed by Cocaine Laced with Veterinary Anti-Parasite Drug SAMHSA, Press Release. http://www.samhsa.gov/newsroom/advisories/090921vet5101.aspx.
25. Fucci N. Unusual adulterants in cocaine seized on Italian clandestine market. Forensic Sci Int 2007, 172:1.
26. Williams G.T., Johnson S.A.N., Dieppe P.A., Huskisson E.C. Neutropenia during treatment of rheumatoid arthritis with levamisole. Ann Rheum Dis 1978, 37:366-369.
27. Schmidt K.L., Mueller-Eckhardt C. Agranulocytosis, levamisole, and HLA-B27. Lancet 1977, 2:85.
28. Espinoza L.R., Dorval G., Osterland C.K. Levamisole-induced adverse reactions and histocompatibility testing in malignant melanoma. Tissue Antigens 1979, 13(3):236-237.
29. Mielants H., Veys E.M.B. 27 and agranulocytosis in rheumatoid arthritis patients treated with levamisole. Acta Rhumatol 1979, 3(2):104-109.
30. Symoens J., Veys E., Mielants M., Pinals R. Adverse reactions to levamisole. Cancer Treat Rep 1978, 62(11):1721-1730.
31. Hodinka L., Geher P., Meretey K., Gyodki E.K., Petranyi G.G., Bozsoky S. Levamisole-induced neutropenia and agranulocytosis: Association with HLA B27 leukocyte agglutinating and lymphocytotoxic antibodies. Int Arch Allergy Appl Immunol 1981, 65:460-464.
32. Drew S.I., Carter B.M., Nathanson D.S., Terasaki P.I. Levamisole-associated neutropenia and autoimmune granulocytotoxins. Ann Rheum Dis 1980, 39:59-63.
33. Brewer J.D., Meves A., Bostwick J.M., Hamacher K.L., Pittelkow M.R. Cocaine abuse: Dermatologic manifestations and therapeutic approaches. J Am Acad Dermatol 2008, 59(3):483-487.
34. Chevalier X., Rostoker G., Larget-Piet B., Gherardi R. Schoenlein-Henoch purpura with necrotizing vasculitis after cocaine snorting. Clin Nephrol 1995, 43:348-349.
35. Enriquez R., Palacios F.O., Gonzalez C.M., Amoros F.A., Cabezuelo J.B., Hernandez F. Skin vasculitis, hypokalemia and acute renal failure in rhabdomyolysis associated with cocaine. Nephron 1991, 59:336-337.
36. Bacharach J.M., Colville D.S., Lie J.T. Accelerated atherosclerosis, aneurysmal disease, and aortitis: possible pathogenic association with cocaine abuse. Internat Angiol 1992, 11:83-86.
37. Hofbauer G.F., Burg G., Nestle F.O. Cocaine related Stevens-Johnson syndrome. Dermatology 2000, 201:258-260.
38. Gertner E., Hamlar D. Necrotizing granulomatous vasculitis associated with cocaine use. J Rheumatol 2002, 29:1795-1797.
39. Orriols R., Munoz X., Ferrer J., Huget P., Morell F. Cocaine induced Churg-Strauss vasculitis. Eur Respir J 1996, 9:175-177.
40. Trozak D.J., Gould W.M. Cocaine abuse and connective tissue disease. J Am Acad Dermatol 1984, 10:525.
41. Balbir-Gurman A., Braun-Moscovici Y., Nahir A.M. Cocaine induced Raynaud's phenomenon and ischemic finger necrosis. Clin Rheumatol 2001, 20:376-378.
42. Zamora-Quezada J.G., Dinerman H., Stadecker M.J., Kelly J.J. Muscle and skin infarction after free-basing cocaine (crack). Ann Intern Med 1988, 108:564-566.
43. Grau R. Pseudovasculitis: mechanisms of vascular injury and clinical spectrum. Curr Rheumatol Rep 2002, 4:83-89.
44. Friedman D.R., Wolfsthal S.D. Cocaine-induced pseudovasculitis. Mayo Clin Proc 2005, 80:671-673.
45. Bhinder S.K., Majithia V. Cocaine use and its rheumatic manifestations: a case report and discussion. Clin Rheumatol 2007, 26:1192-1194.
46. Neynaber S., Mistry-Burchardi N., Rust C., Samtleben W., Burgdorf W.H., Seitz M.A., et al. PR3-ANCA-positive necrotizing multi-organ vasculitis following cocaine abuse. Acta Dermatol Venereol 2008, 88:594-596.
47. Wiesner O., Russell K.A., Lee A.S., Jenne D.E., Trimarchi M., Gregorini G., et al. Antineutrophil cytoplasmic antibodies reacting with human neutrophil elastase as a diagnostic marker for cocaine-induced midline destructive lesions but not autoimmune vasculitis. Arthritis Rheum 2004, 50:2954-2965.
48. Trimarchi M., Gregorini G., Facchetti F., Morassi M.L., Manfredini C., Maroldi R., et al. Cocaine-induced midline destructive lesions. Clinical, radiographic, histopathologic and serologic features and their differentiation from Wegener granulomatosis. Medicine 2001, 80:391-404.
49. Chang S.L., Bersig J., Felix B., Fiala M., House S.D. Chronic cocaine alters hemodynamics and leukocyte-endothelial interactions in rat mesenteric venules. Life Sci 2000, 66(24):2357-2369.
50. Fritsma G.A., Leikin J.B., Maturen A.J., Froelich C.J., Hryhorczuk D.O. Detection of anticardiolipin antibody in patients with cocaine abuse. J Emerg Med 1991, 9:37-43.
51. Siklos P. Levamisole induced arthritis. Br Med J 1977, 2(6089):773.
52. Segal A.W., Pugh S.F., Levi A.J., Loewi G. Levamisole-induced arthritis in Crohn's disease. Br Med J 1977, 2(6086):555.
53. Raymon L.P., Isenschmid D.S. Letter to the editor: the possible role of levamisole in illicit cocaine preparations. J Anal Toxicol 2009, 33(9):620-622.
54. Geller L., Whang T.B., Mercer S.E., Phelps R. Retiform purpura: A new stigmata of illicit drug use?. Dermatol Online J 2011, 17(2):7.